104
Limitations of Foregoing
We have not yet verified that the clinical trial design
will be judged credible by a sufficiently large segment of the
scientific community
•Bayesians
do not regard frequentist inference as relevant
•We
thus need to consider how to evaluate the Bayesian operating
characteristics